Alignment Healthcare Q3: Revenue Up 36.7% to $1.36B, Net Loss of $8.1M as Medical Costs Climb
ALHC sits 21% above its 52-week low of $6.01.
Summary
Alignment Healthcare grew Q3 revenue 36.7% to $1.36 billion but swung to an $8.1 million net loss as the medical benefits ratio rose to 89.5%. The 10-Q also discloses a whistleblower lawsuit alleging accounting irregularities and two CMS Star Ratings lawsuits.
Key Events · Earnings and Guidance · ALHC
-
Q3 Revenue Up 36.7%, Profit Turns Negative
Total revenue was $1,358.3 million versus $993.7 million a year earlier, but the company posted a net loss of $8.1 million compared with net income of $3.7 million in Q3 2025.
-
Medical Benefits Ratio Climbs to 89.5%
The medical benefits ratio rose to 89.5% in Q3 2026 from 87.2% a year earlier, a 2.3-point increase, on higher medical cost trends; adjusted EBITDA fell 32.8% to $21.8 million from $32.4 million.
-
Whistleblower Suit Alleges Accounting Irregularities
A former executive officer sued on July 7, 2026 alleging whistleblower retaliation and constructive discharge after reporting concerns of accounting irregularities; the company says the claims are without merit and has recorded no accrual.
-
Star Ratings Lawsuits Against CMS Filed
The company filed suit on July 10, 2026 challenging CMS's calculation of 2027 Star Ratings (summary judgment fully briefed) and a second suit on October 9, 2026 challenging 2028 ratings; the California H3815 plan, about 75% of membership, fell to 3.5 stars for 2027, affecting 2028 quality bonus payments.
Analysis · ALHC · Finance
Revenue growth of 36.7% is real, but the profit line flipped: a $3.7 million net gain a year ago became an $8.1 million net loss as the medical benefits ratio rose to 89.5% from 87.2%. That margin squeeze is the core issue, and it lands alongside a 2027 Star Ratings downgrade for the plan covering roughly 75% of members that threatens 2028 quality bonus payments. The 10-Q also surfaces items not in the earnings release: a July 2026 whistleblower lawsuit from a former executive alleging he reported accounting irregularities (no accrual booked), two lawsuits against CMS over Star Ratings calculations, and a RADV audit of the California plan for payment year 2019. Cash of $727.7 million and an undrawn $200 million revolver give runway, but the cost trend and the Star Ratings overhang are what will drive the stock.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALHC was trading at $7.29 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $6.01 to $25.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.